Importantly, PRSS3/MTG linked to F2RL1 (also known as PAR2), was reported to modulate inflammation and tumorigenesis in several cancer types, such as colon cancer and breast cancer (23, 24). The gene discussed is F2RL1; the disease is breast cancer.